Skip to main content
Clinical Trials/NCT03779243
NCT03779243
Completed
Not Applicable

Melatonin Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Stanford University1 site in 1 country90 target enrollmentJanuary 7, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Disturbance
Sponsor
Stanford University
Enrollment
90
Locations
1
Primary Endpoint
Mean Change in Pittsburgh Sleep Quality Index Score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality in Orthopaedic trauma patients. We hope to learn if melatonin and sleep education effectively improve sleep following traumatic injury, and improve outcomes.

Registry
clinicaltrials.gov
Start Date
January 7, 2019
End Date
August 24, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael J. Gardner

PROFESSOR OF ORTHOPAEDIC SURGERY AT THE STANFORD UNIVERSITY MEDICAL CENTER

Stanford University

Eligibility Criteria

Inclusion Criteria

  • New patients visiting the Orthopaedic Trauma Clinic or undergoing orthopaedic surgery in Stanford Hospital following traumatic injury. Accidental traumatic fracture injuries that are operative and non-operative. Must be able to swallow tablets.

Exclusion Criteria

  • Documented head trauma. Cognitive impairments. Minors. Previously diagnosed sleep disorders. Sleep apnea. Enrolled in another study. Women who are pregnant or may become pregnant or are nursing. Hypertension. Diabetes. Endocrine, autoimmune, depressive, bleeding or seizure disorders.

Outcomes

Primary Outcomes

Mean Change in Pittsburgh Sleep Quality Index Score

Time Frame: Baseline, week 6, and week 12

9-item self-rated questionnaire that assesses clinical sleep quality and disturbances. Global PSQI scores are sums of the component scores, and range from 0-21. Higher scores indicate worse sleep quality.

Secondary Outcomes

  • 36-Item Short Form Survey (SF-36) to measure quality of life(Baseline, week 6, and week 12)
  • Mean Change from Baseline in Pain Scores on the Visual Analog Scale (VAS)(Baseline, week 6, and week 12)

Study Sites (1)

Loading locations...

Similar Trials